Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Cognitive Phenotyping and Interpretation of Alzheimer Blood Biomarkers
Bouteloup, Vincent; Villain, Nicolas; Vidal, Jean Sebastien; Gonzalez-Ortiz, Fernando; Yuksekel, Idil; Santos, Cristiano; Schraen-Maschken, Susanna; Pellegrin, Isabelle; Lehmann, Sylvain; Blennow, Kaj; Chene, Genevieve; Hanon, Olivier; Dufouil, Carole Share Save Plasma Hepcidin as a potential informative biomarker of Alzheimer disease and vascular dementiaDelaby, Constance; Alcolea, Daniel; Busto, Germain; Gabelle, Audrey; Ayrignac, Xavier; Bennys, Karim; Muino, Elena; Villatoro, Paula; Fernandez-Cadenas, Israel; Pradeilles, Nicolas; El Bounasri, Shaima; Torres, Soraya; Hirtz, Christophe; Zetterberg, Henrik; Lleo, Alberto; Fortea, Juan; Lehmann, Sylvain Share Save Share Save Share Save Plasma p-tau181 and GFAP reflect 7T MR-derived changes in Alzheimer's disease: A longitudinal study of structural and functionalMRI andMRSGöschel, L; Dell'Orco, A; Fillmer, A; Aydin, S; Ittermann, B; Riemann, L; Lehmann, S; Cano, S; Melin, J; Pendrill, L; Hoede, PL; Teunissen, CE; Schwarz, C; Grittner, U; Körtvélyessy, P; Flöel, A Share Save Share Save Clarifying the association of CSF Aβ, tau, BACE1, and neurogranin with AT(N) stages in Alzheimer diseaseLehmann, Sylvain; Schraen-Maschke, Susanna; Buee, Luc; Vidal, Jean-Sebastien; Delaby, Constance; Hirtz, Christophe; Blanc, Frederic; Paquet, Claire; Allinquant, Bernadette; Bombois, Stephanie; Gabelle, Audrey; Hanon, Olivier Share Save The endolysosomal system in conventional and unconventional protein secretionNeel, Eloise; Chiritoiu-Butnaru, Marioara; Fargues, William; Denus, Morgane; Colladant, Maelle; Filaquier, Aurore; Stewart, Sarah E.; Lehmann, Sylvain; Zurzolo, Chiara; Rubinsztein, David C.; Marin, Philippe; Parmentier, Marie-Laure; Villeneuve, Julien Share Save Association of caffeine consumption with cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease: A BALTAZAR cohort studyBlum, David; Cailliau, Emeline; Behal, Helene; Vidal, Jean-Sebastien; Delaby, Constance; Buee, Luc; Allinquant, Bernadette; Gabelle, Audrey; Bombois, Stephanie; Lehmann, Sylvain; Schraen-Maschke, Susanna; Hanon, Olivier Share Save Share Save CD138 as a Specific CSF Biomarker of Multiple SclerosisHinsinger, Geoffrey; De Terdonck, Lucile Du Trieu; Urbach, Serge; Salvetat, Nicolas; Rival, Manon; Galoppin, Manon; Ripoll, Chantal; Cezar, Renaud; Laurent-Chabalier, Sabine; Demattei, Christophe; Agherbi, Hanane; Castelnovo, Giovanni; Lehmann, Sylvain; Rigau, Valerie; Marin, Philippe; Thouvenot, Eric Share Save Clinical value of plasma ALZpath pTau217 immunoassay for assessing mild cognitive impairmentLehmann, Sylvain; Schraen-Maschke, Susanna; Vidal, Jean-Sebastien; Delaby, Constance; Buee, Luc; Blanc, Frederic; Paquet, Claire; Allinquant, Bernadette; Bombois, Stephanie; Gabelle, Audrey; Hanon, Olivier Share Save Neurofilaments as biomarkers in neurological disorders - towards clinical applicationKhalil, Michael; Teunissen, Charlotte E.; Lehmann, Sylvain; Otto, Markus; Piehl, Fredrik; Ziemssen, Tjalf; Bittner, Stefan; Sormani, Maria Pia; Gattringer, Thomas; Abu-Rumeileh, Samir; Thebault, Simon; Abdelhak, Ahmed; Green, Ari; Benkert, Pascal; Kappos, Ludwig; Comabella, Manuel; Tumani, Hayrettin; Freedman, Mark S.; Petzold, Axel; Blennow, Kaj; Zetterberg, Henrik; Leppert, David; Kuhle, Jens Share Save The free plasma amyloid A β 1-42 /A β 1-40 ratio predicts conversion to dementia for subjects with mild cognitive impairment with performance equivalent to that of the total plasma A β 1-42 /A β 1-40 ratio. The BALTAZAR studySchraen-Maschke, S.; Duhamel, A.; Vidal, J. S.; Ramdane, N.; Vaudran, L.; Dussart, C.; Buee, L.; Sablonniere, B.; Delaby, C.; Allinquant, B.; Gabelle, A.; Bombois, S.; Lehmann, S.; Hanon, O. Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
